Literature DB >> 29486183

Nrf-2 transcriptionally activates P21Cip/WAF1 and promotes A549 cell survival against oxidative stress induced by H2O2.

Samarjit Jana1, Kartick Patra1, Jagannath Jana2, Deba Prasad Mandal3, Shamee Bhattacharjee4.   

Abstract

Cancer cells possess elevated ROS coupled with increased levels of antioxidant enzymes which render them resistant against cytotoxic chemotherapies. Therefore, an understanding of the interaction between key molecules involved in stress adaptive mechanisms is important to innovate strategies against cancer cell chemoresistance. Here, the lung adenocarcinoma cell line A549 with constitutively expressed Nrf2 was found to be more tolerant to H2O2 (0.1, 0.2, 0.5 and 1 mM) than normal lung cell line L132 or p53 null lung cancer cell line H1299. Maximum cytoprotection was observed at 0.2 mM H2O2 accompanied by a significant increase in p21, Nrf2 and antioxidant enzymes in A549 cells. The increased p21 expression was independent of p53 but dependent on Nrf2 as evident from qPCR, Western blotting and dual luciferase assays after silencing Nrf-2 and p53 genes. Highly conserved Nrf-2 binding sites were identified in p21 promoter by bioinformatics and homology modeling which was further confirmed by ChIP and reporter assay.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Nrf-2; Oxidative stress; Transcriptional activation; p21; p53

Mesh:

Substances:

Year:  2018        PMID: 29486183     DOI: 10.1016/j.cbi.2018.02.030

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  7 in total

1.  Transcription Factor NRF2 Participates in Cell Cycle Progression at the Level of G1/S and Mitotic Checkpoints.

Authors:  Diego Lastra; Maribel Escoll; Antonio Cuadrado
Journal:  Antioxidants (Basel)       Date:  2022-05-11

2.  ROS-Induced GATA4 and GATA6 Downregulation Inhibits StAR Expression in LPS-Treated Porcine Granulosa-Lutein Cells.

Authors:  Xiaolu Qu; Leyan Yan; Rihong Guo; Hui Li; Zhendan Shi
Journal:  Oxid Med Cell Longev       Date:  2019-04-22       Impact factor: 6.543

3.  p53 as a hub in cellular redox regulation and therapeutic target in cancer.

Authors:  Sofi E Eriksson; Sophia Ceder; Vladimir J N Bykov; Klas G Wiman
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 6.216

Review 4.  H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy.

Authors:  Marta Hałasa; Anna Wawruszak; Alicja Przybyszewska; Anna Jaruga; Małgorzata Guz; Joanna Kałafut; Andrzej Stepulak; Marek Cybulski
Journal:  Cells       Date:  2019-05-22       Impact factor: 6.600

5.  The effect of cysteine oxidation on DJ-1 cytoprotective function in human alveolar type II cells.

Authors:  Karim Bahmed; Samia Boukhenouna; Loukmane Karim; Tessa Andrews; Jiusheng Lin; Robert Powers; Mark A Wilson; Chih-Ru Lin; Elise Messier; Nichole Reisdorph; Roger L Powell; Hsin-Yao Tang; Robert J Mason; Gerard J Criner; Beata Kosmider
Journal:  Cell Death Dis       Date:  2019-09-02       Impact factor: 8.469

6.  Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.

Authors:  Katarína Smolková; Edit Mikó; Tünde Kovács; Alberto Leguina-Ruzzi; Adrienn Sipos; Péter Bai
Journal:  Antioxid Redox Signal       Date:  2020-03-18       Impact factor: 8.401

Review 7.  [Role of P21 in Resistance of Lung Cancer].

Authors:  Tian Fu; Ailing Liang; Yongjun Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-05-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.